Menu
GeneBe

1-11948023-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_000302.4(PLOD1):c.124C>T(p.Arg42Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R42H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

PLOD1
NM_000302.4 missense

Scores

2
6
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 1.31
Variant links:
Genes affected
PLOD1 (HGNC:9081): (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) Lysyl hydroxylase is a membrane-bound homodimeric protein localized to the cisternae of the endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VI have deficiencies in lysyl hydroxylase activity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3478949).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLOD1NM_000302.4 linkuse as main transcriptc.124C>T p.Arg42Cys missense_variant 2/19 ENST00000196061.5
PLOD1NM_001316320.2 linkuse as main transcriptc.265C>T p.Arg89Cys missense_variant 3/20

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLOD1ENST00000196061.5 linkuse as main transcriptc.124C>T p.Arg42Cys missense_variant 2/191 NM_000302.4 P1Q02809-1

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152154
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000915
AC:
23
AN:
251494
Hom.:
0
AF XY:
0.0000883
AC XY:
12
AN XY:
135922
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000167
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000242
AC:
354
AN:
1461678
Hom.:
0
Cov.:
30
AF XY:
0.000243
AC XY:
177
AN XY:
727148
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.0000374
Gnomad4 NFE exome
AF:
0.000300
Gnomad4 OTH exome
AF:
0.000166
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152154
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.0000882
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000122
Hom.:
0
Bravo
AF:
0.0000756
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, no assertion criteria providedprovider interpretationStanford Center for Inherited Cardiovascular Disease, Stanford UniversityJul 13, 2017PLOD1, Exon 2, c.124C>T (p.Arg42Cys) - Heterozygous (NM_000302.3) Chromosome location 1:12008080 C / T Testing was conducted at Invitae laboratory. The PLOD1 gene is associated with autosomal recessive Ehlers-Danlos syndrome, kyphoscoliotic form (MedGen UID: 75672). Our patient has not been diagnosed with this condition. We classify this as a Variant of Uncertain Significance (VUS). Because Ehlers-Danlos syndrome, kyphoscoliotic form, is autosomal recessive, any single variant is not expected to cause disease. This variant has not been reported in the literature in association with disease. It has not yet been reported to ClinVar. There are no missense variants listed in ClinVar as Likely Pathogenic or Pathogenic within 10 amino acids of this codon. Of note, the variants in this gene that are classified in ClinVar as Pathogenic are predominantly truncating: nonsense, frameshift, and splice site variants—and are not missense variants like this one. The Arginine at codon 42 is conserved across mammals but is poorly conserved across other vertebrate species. Cysteine is not the default amino acid in any species. This is a nonconservative amino acid change, from a positively-charged Arginine to a polar Cysteine capable of forming disulfide bridges. According to the Invitae report, algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant is present in 25 out of 140,000 individuals in gnomAD, for an overall MAF of 0. 009%. The highest MAF is among individuals with non-Finnish European ancestry: 0.01657% (21/126,728 alleles). -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 27, 2020In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2020- -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 06, 2024The p.R42C variant (also known as c.124C>T), located in coding exon 2 of the PLOD1 gene, results from a C to T substitution at nucleotide position 124. The arginine at codon 42 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Ehlers-Danlos syndrome, kyphoscoliotic type 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 25, 2022This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 42 of the PLOD1 protein (p.Arg42Cys). This variant is present in population databases (rs202003686, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PLOD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 459806). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PLOD1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.26
Cadd
Pathogenic
33
Dann
Pathogenic
1.0
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.96
D;D;D
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.35
T;T;T
MetaSVM
Benign
-0.97
T
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Benign
0.48
T
PROVEAN
Pathogenic
-4.7
D;D;D
REVEL
Benign
0.19
Sift
Uncertain
0.0070
D;D;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
1.0
.;.;D
Vest4
0.69
MVP
0.69
MPC
0.75
ClinPred
0.83
D
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.26
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs202003686; hg19: chr1-12008080; API